IL58849A
(en)
*
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
US4595675A
(en)
*
|
1979-09-19 |
1986-06-17 |
Hoechst Aktiengesellschaft |
Bicyclic α-iminocarboxylic acid compounds having hypotensive activity
|
US4616030A
(en)
*
|
1979-12-07 |
1986-10-07 |
Adir |
Perhydroindole-2-carboxylic acids as antihypertensives
|
US4508729A
(en)
*
|
1979-12-07 |
1985-04-02 |
Adir |
Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
|
US4616031A
(en)
*
|
1979-12-07 |
1986-10-07 |
Adir |
Perhydroindole-2-carboxylic acids as antihypertensives
|
US4616029A
(en)
*
|
1979-12-07 |
1986-10-07 |
Adir |
Perhydromdole-2-carboxylic acids as antihypertensives
|
FR2503155A2
(fr)
*
|
1980-10-02 |
1982-10-08 |
Science Union & Cie |
Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
|
US4644008A
(en)
*
|
1979-12-07 |
1987-02-17 |
Adir |
Perhydroindole-2-carboxylic acids as antihypertensives
|
JPS5683483A
(en)
*
|
1979-12-13 |
1981-07-08 |
Santen Pharmaceut Co Ltd |
Thiazolidine compound
|
US4350704A
(en)
*
|
1980-10-06 |
1982-09-21 |
Warner-Lambert Company |
Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
|
IE52663B1
(en)
*
|
1980-04-02 |
1988-01-20 |
Warner Lambert Co |
Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids
|
FR2480747A1
(fr)
*
|
1980-04-17 |
1981-10-23 |
Roques Bernard |
Derives d'acides amines et leur application therapeutique
|
PT73522B
(en)
*
|
1980-08-18 |
1983-07-14 |
Merck & Co Inc |
Process for preparing substituted caprylolactam derivatives as antihypertensives
|
IL63540A0
(en)
*
|
1980-08-18 |
1981-11-30 |
Merck & Co Inc |
Substituted enantholactam derivatives as antihypertensives
|
GR74635B
(da)
*
|
1980-08-18 |
1984-06-29 |
Merck & Co Inc |
|
GR75019B
(da)
*
|
1980-09-17 |
1984-07-12 |
Univ Miami |
|
US4344949A
(en)
*
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
GR75775B
(da)
*
|
1980-10-06 |
1984-08-02 |
Merck & Co Inc |
|
ZA817261B
(en)
*
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
EP0050800B2
(en)
*
|
1980-10-23 |
1995-06-07 |
Schering Corporation |
Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
|
US4296110A
(en)
*
|
1980-10-28 |
1981-10-20 |
E. I. Du Pont De Nemours And Company |
Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
|
AU543804B2
(en)
*
|
1980-10-31 |
1985-05-02 |
Takeda Chemical Industries Ltd. |
Amides having bicyclic substituents on nitrogen
|
GB2086390B
(en)
*
|
1980-11-03 |
1984-06-06 |
Ciba Geigy Ag |
1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
|
US4462943A
(en)
*
|
1980-11-24 |
1984-07-31 |
E. R. Squibb & Sons, Inc. |
Carboxyalkyl amino acid derivatives of various substituted prolines
|
IE53315B1
(en)
*
|
1980-12-18 |
1988-10-12 |
Schering Corp |
Substituted dipeptides,processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
|
US4906615A
(en)
*
|
1980-12-18 |
1990-03-06 |
Schering Corporation |
Substituted dipeptides as inhibitors of enkephalinases
|
EP0054862B1
(en)
*
|
1980-12-18 |
1985-11-27 |
Schering Corporation |
Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
|
DE3260505D1
(en)
*
|
1981-01-23 |
1984-09-13 |
Takeda Chemical Industries Ltd |
Alicyclic compounds, their production and use
|
US4532342A
(en)
*
|
1981-02-20 |
1985-07-30 |
Warner-Lambert Company |
N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
EP0059966B1
(en)
*
|
1981-03-09 |
1986-08-13 |
Merck & Co. Inc. |
Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
|
US4512979A
(en)
|
1981-03-23 |
1985-04-23 |
Merck & Co., Inc. |
Dipeptides containing thialysine and related amino acids as antihypertensives
|
AU556932B2
(en)
*
|
1981-03-30 |
1986-11-27 |
Usv Pharmaceutical Corp. |
Dipetide with heterocyclic groiup
|
US4820729A
(en)
*
|
1981-03-30 |
1989-04-11 |
Rorer Pharmaceutical Corporation |
N-substituted-amido-amino acids
|
US4510322A
(en)
*
|
1981-07-13 |
1985-04-09 |
Merck & Co., Inc. |
Indacrinone having enhanced uricosuric
|
US4454291A
(en)
*
|
1981-07-20 |
1984-06-12 |
American Home Products Corporation |
N-(2-Substituted-1-oxoalkyl)-2,3-dihydro-1H-indole-2-carboxylic acid derivatives
|
US4454292A
(en)
*
|
1981-07-20 |
1984-06-12 |
American Home Products Corporation |
N-[2-Substituted-1-oxoalkyl]-2,3-dihydro-1H-indole-2-carboxylic acid derivatives
|
CS226907B1
(en)
*
|
1981-08-07 |
1984-04-16 |
Kasafirek Evzen |
Alkylamides of carboxyalkanoylpeptides
|
ZA826022B
(en)
*
|
1981-08-21 |
1983-08-31 |
Univ Miami |
Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
|
US4766110A
(en)
*
|
1981-08-21 |
1988-08-23 |
Ryan James W |
Novel complex amido and imido derivatives of carboxyalkyl peptides
|
DE3226768A1
(de)
*
|
1981-11-05 |
1983-05-26 |
Hoechst Ag, 6230 Frankfurt |
Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
|
US4410520A
(en)
*
|
1981-11-09 |
1983-10-18 |
Ciba-Geigy Corporation |
3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
|
EP0079521A1
(en)
*
|
1981-11-09 |
1983-05-25 |
Merck & Co. Inc. |
Process for preparation of carboxyalkyldipeptide derivatives
|
EP0079522B1
(en)
*
|
1981-11-09 |
1986-05-07 |
Merck & Co. Inc. |
N-carboxymethyl(amidino)lysyl-proline antihypertensive agents
|
EP0081094A1
(en)
*
|
1981-11-12 |
1983-06-15 |
Merck & Co. Inc. |
Substituted omega-amino-carboxymethyldipeptide antihypertensive agents
|
EP0080822A1
(en)
*
|
1981-11-27 |
1983-06-08 |
Beecham Group Plc |
Anti-hypertensive prolinol-based peptides
|
US4503043A
(en)
*
|
1981-12-07 |
1985-03-05 |
Warner-Lambert Company |
Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids
|
CA1341296C
(en)
*
|
1981-12-29 |
2001-09-25 |
Hansjorg Urbach |
2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
|
JPS58126851A
(ja)
*
|
1982-01-11 |
1983-07-28 |
メルク エンド カムパニー インコーポレーテッド |
抗高血圧剤として有用なアミノアシル含有ジペプチド誘導体
|
US4555502A
(en)
*
|
1982-09-30 |
1985-11-26 |
Merck & Co., Inc. |
Aminoacyl-containing dipeptide derivatives useful as antihypertensives
|
DE3378266D1
(en)
*
|
1982-01-11 |
1988-11-24 |
Merck & Co Inc |
Aminoacyl-containing dipeptide derivatives useful as antihypertensives
|
IE54551B1
(en)
*
|
1982-01-22 |
1989-11-22 |
Ici Plc |
Amide derivatives
|
US4665087A
(en)
*
|
1982-02-22 |
1987-05-12 |
Ciba-Geigy Corporation |
1-(carbamyl, thiocarbamyl, and iminocarbamyl)-indoline derivatives
|
DE3360065D1
(en)
*
|
1982-03-08 |
1985-03-28 |
Schering Corp |
Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
|
US4410807A
(en)
*
|
1982-03-26 |
1983-10-18 |
Kay Industries, Inc. |
Regulating device for polyphase electrical circuits
|
DE3211397A1
(de)
*
|
1982-03-27 |
1983-11-10 |
Hoechst Ag, 6230 Frankfurt |
Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
|
DE3211676A1
(de)
*
|
1982-03-30 |
1983-10-06 |
Hoechst Ag |
Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
|
JPS58188847A
(ja)
*
|
1982-04-26 |
1983-11-04 |
Takeda Chem Ind Ltd |
ペプチド誘導体
|
US4681886A
(en)
*
|
1982-04-30 |
1987-07-21 |
E. R. Squibb & Sons, Inc. |
Substituted 4-phenoxy or 4-phenylthio prolines
|
US4555503A
(en)
*
|
1982-05-05 |
1985-11-26 |
Merck & Co., Inc. |
N2 -(Substituted)carboxymethyl-N6 -(substituted)-lysyl-and αε-aminoalkyl)glycyl amino acid antihypertensive agents
|
US4483850A
(en)
*
|
1982-05-10 |
1984-11-20 |
Merck & Co., Inc. |
N-Terminal substituted oligopeptide converting enzyme inhibitors
|
GB2128984B
(en)
*
|
1982-05-12 |
1985-05-22 |
Hoffmann La Roche |
Diaza-bicyclic compounds
|
NZ204130A
(en)
*
|
1982-05-12 |
1986-03-14 |
Hoffmann La Roche |
Bicyclic heterocyclic compounds and pharmaceutical compositions
|
ZA832844B
(en)
*
|
1982-05-18 |
1984-03-28 |
Smithkline Beckman Corp |
Oligopeptide prodrugs
|
JPS6058233B2
(ja)
*
|
1982-05-24 |
1985-12-19 |
田辺製薬株式会社 |
2−オキソイミダゾリジン誘導体及びその製法
|
US4442030A
(en)
*
|
1982-06-07 |
1984-04-10 |
Merck & Co., Inc. |
Process for preparing carboxyalkyl dipeptides
|
DE3376649D1
(en)
*
|
1982-06-17 |
1988-06-23 |
Schering Corp |
Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions
|
US4442089A
(en)
*
|
1982-07-06 |
1984-04-10 |
E. R. Squibb & Sons, Inc. |
Method for treating glaucoma with topical or systemic ACE inhibitor compositions
|
US4470973A
(en)
*
|
1982-07-19 |
1984-09-11 |
E. R. Squibb & Sons, Inc. |
Substituted peptide compounds
|
US4473575A
(en)
*
|
1982-07-19 |
1984-09-25 |
Ciba-Geigy Corporation |
3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
|
IL69136A0
(en)
*
|
1982-07-19 |
1983-10-31 |
Squibb & Sons Inc |
Substituted peptide compounds
|
US4736066A
(en)
*
|
1982-07-19 |
1988-04-05 |
E. R. Squibb & Sons, Inc. |
Intermediate for substituted peptide compounds
|
AU560285B2
(en)
*
|
1982-07-19 |
1987-04-02 |
Imperial Chemical Industries Plc |
Heterocyclyl carbonyl sulphonamides
|
US4661515A
(en)
*
|
1982-07-21 |
1987-04-28 |
Usv Pharmaceutical Corporation |
Compounds having angiotensin converting enzyme inhibitory activity and diuretic activity
|
US4621092A
(en)
*
|
1982-07-22 |
1986-11-04 |
E. R. Squibb & Sons, Inc. |
Substituted proline compounds, composition and method of use
|
US4742067A
(en)
*
|
1982-07-22 |
1988-05-03 |
E. R. Squibb & Sons, Inc. |
Acylalkylaminocarbonyl substituted amino and imino acid compounds
|
US4487716A
(en)
*
|
1982-08-23 |
1984-12-11 |
American Home Products Corporation |
N-(1-Carboxy-3-phenylpropyl)-dipeptides
|
US4439364A
(en)
*
|
1982-09-01 |
1984-03-27 |
E. I. Du Pont De Nemours & Company |
Process for preparing antihypertensive 1-substituted cyclic lactam-2-carboxylic acids and their derivatives
|
US4866173A
(en)
*
|
1982-09-22 |
1989-09-12 |
Rorer Pharmaceutical Corporation |
Therapeutic substituted semicarbazides
|
US4500713A
(en)
*
|
1982-09-23 |
1985-02-19 |
Usv Pharmaceutical Corporation |
Therapeutic dipeptides
|
US4634716A
(en)
*
|
1982-09-30 |
1987-01-06 |
Merck & Co., Inc. |
Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents
|
US4587234A
(en)
*
|
1982-11-18 |
1986-05-06 |
E. R. Squibb & Sons, Inc. |
Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
|
US4499079A
(en)
*
|
1982-11-18 |
1985-02-12 |
E. R. Squibb & Sons, Inc. |
Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
|
US4642315A
(en)
*
|
1982-11-18 |
1987-02-10 |
E. R. Squibb & Sons, Inc. |
Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
|
US4482544A
(en)
*
|
1982-11-29 |
1984-11-13 |
Usv Pharmaceutical Corporation |
Compounds for treating hypertension
|
US4456595A
(en)
*
|
1982-12-06 |
1984-06-26 |
E. R. Squibb & Sons, Inc. |
Carboxy and substituted carboxy aroly peptides
|
US4826812A
(en)
*
|
1982-12-27 |
1989-05-02 |
Schering Corporation |
Antiglaucoma agent
|
US4496541A
(en)
*
|
1983-01-12 |
1985-01-29 |
Usv Pharmaceutical Corporation |
Compounds for treating hypertension
|
DE3300774A1
(de)
*
|
1983-01-12 |
1984-07-12 |
Hoechst Ag, 6230 Frankfurt |
Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung
|
DE3302125A1
(de)
*
|
1983-01-22 |
1984-07-26 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
|
EP0115091A1
(en)
*
|
1983-01-27 |
1984-08-08 |
ENI-Ente Nazionale Idrocarburi |
N-carboxyacyl derivatives of cyclic amino acids, useful as antihypertensives
|
US4659711A
(en)
*
|
1983-01-31 |
1987-04-21 |
Usv Pharmaceutical Corporation |
1,2,3,4-Tetrahydrophthalazine and hexahydropyridazine compounds for treating hypertension
|
US5175306A
(en)
*
|
1983-01-31 |
1992-12-29 |
Hoechst Aktiengesellschaft |
Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
|
US4711884A
(en)
*
|
1983-02-28 |
1987-12-08 |
E. R. Squibb & Sons, Inc. |
Thiazine and thiazepine containing compounds
|
US4666906A
(en)
*
|
1983-03-16 |
1987-05-19 |
Usv Pharmaceutical Corporation |
Compounds for treating hypertension
|
US4596791A
(en)
*
|
1983-03-16 |
1986-06-24 |
Usv Pharmaceutical Corp. |
Compounds for treating hypertension
|
US4481191A
(en)
*
|
1983-03-30 |
1984-11-06 |
The Regents Of The University Of California |
Method for controlling blood pressure
|
GB8311286D0
(en)
*
|
1983-04-26 |
1983-06-02 |
Searle & Co |
Carboxyalkyl peptide derivatives
|
US4585758A
(en)
*
|
1983-05-20 |
1986-04-29 |
Usv Pharmaceutical Corp. |
Angiotensin-converting enzyme inhibitors
|
ZA843899B
(en)
*
|
1983-05-23 |
1984-12-24 |
Usv Pharma Corp |
Compounds for treating hypertension
|
US4574079A
(en)
*
|
1983-05-27 |
1986-03-04 |
Gavras Haralambos P |
Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
|
US4783444A
(en)
*
|
1984-09-17 |
1988-11-08 |
Schering Corporation |
Antiglaucoma compositions and methods
|
US4840772A
(en)
*
|
1983-06-02 |
1989-06-20 |
Schering Corporation |
Antiglaucoma compositions and methods
|
US4584285A
(en)
*
|
1983-06-02 |
1986-04-22 |
Schering Corporation |
Antihypertensive agents
|
US4472384A
(en)
*
|
1983-06-15 |
1984-09-18 |
Merck & Co., Inc. |
Antihypertensive composition
|
US4514391A
(en)
*
|
1983-07-21 |
1985-04-30 |
E. R. Squibb & Sons, Inc. |
Hydroxy substituted peptide compounds
|
DE3333454A1
(de)
*
|
1983-09-16 |
1985-04-11 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
|
DE3333455A1
(de)
*
|
1983-09-16 |
1985-04-11 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur herstellung n-alkylierter dipeptide und deren estern
|
EP0137746A3
(en)
*
|
1983-09-22 |
1986-01-08 |
FISONS plc |
Nitrogen substituted angiotensin converting enzyme inhibitors
|
US4642355A
(en)
*
|
1984-02-24 |
1987-02-10 |
Otsuka Pharmaceutical Factory, Inc. |
Proline derivatives
|
EP0181342B1
(en)
*
|
1984-03-01 |
1992-10-28 |
ERK, Vernon |
Method of treating hypertension in vertebrates
|
FI850948L
(fi)
*
|
1984-03-12 |
1985-09-13 |
Pfizer |
Renin inhibitorer som innehaoller statin eller dess derivat.
|
US4536501A
(en)
*
|
1984-03-30 |
1985-08-20 |
E. R. Squibb & Sons, Inc. |
Substituted 4-phenoxy or 4-phenylthio prolines
|
US5684016A
(en)
*
|
1984-04-12 |
1997-11-04 |
Hoechst Aktiengesellschaft |
Method of treating cardiac insufficiency
|
DE3413710A1
(de)
*
|
1984-04-12 |
1985-10-24 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur behandlung der herzinsuffizienz
|
DE3482590D1
(de)
|
1984-04-12 |
1990-08-02 |
Searle & Co |
Carboxyalkyl-peptid-derivate.
|
US4568666A
(en)
*
|
1984-10-18 |
1986-02-04 |
G. D. Searle & Co. |
Carboxylalkyl peptide derivatives
|
US4500518A
(en)
*
|
1984-04-19 |
1985-02-19 |
E. R. Squibb & Sons, Inc. |
Amino thiol dipeptides
|
US4558150A
(en)
*
|
1984-04-19 |
1985-12-10 |
E. R. Squibb & Sons, Inc. |
Intermediates for preparing amino thiol dipeptides
|
AU569789B2
(en)
*
|
1984-05-03 |
1988-02-18 |
Brigham And Women's Hospital |
A.c.e. inhibitors to treat renal diseases
|
US4558037A
(en)
*
|
1984-06-04 |
1985-12-10 |
Merck & Co., Inc. |
Cardiovascular composition
|
EP0168769A3
(en)
*
|
1984-07-16 |
1989-02-08 |
Merck & Co. Inc. |
Process for preparing carboxyalkyl dipeptides
|
US4801721A
(en)
*
|
1984-08-16 |
1989-01-31 |
Ryan James W |
Stereospecific synthesis of carboxyalkyl peptides
|
USH642H
(en)
|
1984-08-20 |
1989-06-06 |
E. R. Squibb & Sons, Inc. |
Substituted urido amino and imino acids and esters
|
US4626545A
(en)
*
|
1984-08-27 |
1986-12-02 |
Merck & Co., Inc. |
Amino acid derivatives as enzyme inhibitors
|
DE3431541A1
(de)
*
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
GB8422165D0
(en)
*
|
1984-09-01 |
1984-10-03 |
Wellcome Found |
Compounds
|
US4746676A
(en)
*
|
1984-09-12 |
1988-05-24 |
Rorer Pharmaceutical Corporation |
Carboxyalkyl dipeptide compounds
|
IT1176983B
(it)
*
|
1984-10-16 |
1987-08-26 |
Zambon Spa |
Dipeptidi ad attivita' farmacologica
|
DE3437917A1
(de)
*
|
1984-10-17 |
1986-04-17 |
Bayer Ag, 5090 Leverkusen |
Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
|
FR2575163B1
(fr)
*
|
1984-12-20 |
1987-03-20 |
Sanofi Sa |
Tri- et tetrapeptides reduits inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
|
CS250699B2
(en)
*
|
1984-12-21 |
1987-05-14 |
Pfizer |
Method of octahydro-6-azaindole's depetidic derivatives production
|
EP0187037A3
(en)
*
|
1984-12-21 |
1988-03-23 |
Takeda Chemical Industries, Ltd. |
Piperidine derivatives, their production and use
|
US4762821A
(en)
*
|
1985-03-22 |
1988-08-09 |
Syntex (U.S.A.) Inc. |
N',N"-dialkylguanidino dipeptides
|
CN86101850A
(zh)
*
|
1985-03-22 |
1987-02-04 |
森得克斯(美国)有限公司 |
N,n′-二烷基胍基二肽的制造方法与用途
|
EP0201741B1
(en)
*
|
1985-04-16 |
1991-07-31 |
Suntory Limited |
Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
|
ES8604609A1
(es)
*
|
1985-07-02 |
1986-02-01 |
Uriach & Cia Sa J |
Procedimiento para la obtencion de la 1-(n-(1(r,s)-(etoxi- carbonil)-3-fenilpropil)-l-alanil)-l-prolina
|
EP0217519B1
(en)
|
1985-08-31 |
1992-02-05 |
FISONS plc |
5-membered heterocyclic ring angiotensin converting enzyme inhibitors
|
US5256687A
(en)
*
|
1985-09-09 |
1993-10-26 |
Hoechst Aktiengesellschaft |
Pharmaceutical composition for the treatment of high blood pressure
|
DE3532036A1
(de)
*
|
1985-09-09 |
1987-03-26 |
Hoechst Ag |
Pharmazeutische zubereitung zur behandlung des bluthochdrucks
|
US5231080A
(en)
*
|
1985-10-15 |
1993-07-27 |
Hoechst Aktiengesellschaft |
Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
|
GB2182938B
(en)
*
|
1985-11-13 |
1989-11-08 |
Otsuka Pharma Co Ltd |
Antihypertensive proline peptides
|
JPH0653757B2
(ja)
*
|
1985-12-06 |
1994-07-20 |
味の素株式会社 |
プロリン誘導体の芳香族スルホン酸塩
|
JPH0662671B2
(ja)
*
|
1986-01-17 |
1994-08-17 |
株式会社大塚製薬工場 |
プロリン誘導体
|
US4771037A
(en)
*
|
1986-01-21 |
1988-09-13 |
Ici Americas Inc. |
N-carboxyalkyl compounds
|
DK103487A
(da)
*
|
1986-02-28 |
1987-08-29 |
Wellcome Found |
Forbindelser der paa samme tid er beta-blokkere og ace-inhibitorer
|
PT84378B
(en)
*
|
1986-02-28 |
1989-01-24 |
Wellcome Found |
New compounds
|
US5231084A
(en)
*
|
1986-03-27 |
1993-07-27 |
Hoechst Aktiengesellschaft |
Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
|
EP0239306B1
(en)
|
1986-03-27 |
1993-06-02 |
Merck Frosst Canada Inc. |
Tetrahydrocarbazole esters
|
US4738850A
(en)
*
|
1986-05-27 |
1988-04-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation and method
|
EP0566157A1
(en)
|
1986-06-20 |
1993-10-20 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
EP0254032A3
(en)
*
|
1986-06-20 |
1990-09-05 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
US4749688A
(en)
*
|
1986-06-20 |
1988-06-07 |
Schering Corporation |
Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
AT395012B
(de)
*
|
1986-06-27 |
1992-08-25 |
Richter Gedeon Vegyeszet |
Verfahren zur herstellung von n-(1(s)|thoxycarbonyl-3-phenyl-propyl)-(s)-alanyl-(s)prolin und von dessen saeureadditionssalzen
|
DE3627613A1
(de)
*
|
1986-08-14 |
1988-02-18 |
Merck Patent Gmbh |
Pharmazeutische zubereitung
|
EP0260118B1
(en)
*
|
1986-09-10 |
1991-12-04 |
Syntex (U.S.A.) Inc. |
Selective amidination of diamines
|
US5948939A
(en)
*
|
1986-09-10 |
1999-09-07 |
Syntex (U.S.A.) Inc. |
Selective amidination of diamines
|
DE3633496A1
(de)
*
|
1986-10-02 |
1988-04-14 |
Hoechst Ag |
Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
|
DE3639879A1
(de)
*
|
1986-11-21 |
1988-06-01 |
Hoechst Ag |
Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung
|
JPH075633B2
(ja)
*
|
1987-02-19 |
1995-01-25 |
アサヒビール株式会社 |
アミノ酸誘導体その製造方法及び血圧降下剤
|
CA1313724C
(en)
*
|
1987-02-19 |
1993-02-16 |
Shizuo Saito |
Aminoacid derivatives as antihypertensives
|
US4837354A
(en)
*
|
1987-02-26 |
1989-06-06 |
Merrell Dow Pharmaceuticals Inc. |
Process for making and isolating (R)-2-hydroxy-4-phenylbutyric acid and esters
|
US5262436A
(en)
*
|
1987-03-27 |
1993-11-16 |
Schering Corporation |
Acylamino acid antihypertensives in the treatment of congestive heart failure
|
JPH0657707B2
(ja)
*
|
1987-05-25 |
1994-08-03 |
吉富製薬株式会社 |
ピペリジン化合物
|
CA1337400C
(en)
*
|
1987-06-08 |
1995-10-24 |
Norma G. Delaney |
Inhibitors of neutral endopeptidase
|
DE3722007A1
(de)
*
|
1987-07-03 |
1989-01-12 |
Hoechst Ag |
Verfahren zur herstellung bicyclischer aminocarbonsaeuren, zwischenprodukte dieses verfahrens und deren verwendung
|
FR2619813B1
(fr)
*
|
1987-08-28 |
1991-05-03 |
Adir |
Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
USH734H
(en)
|
1988-03-07 |
1990-02-06 |
E. R. Squibb & Sons, Inc. |
Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
|
DE3739690A1
(de)
*
|
1987-11-24 |
1989-06-08 |
Hoechst Ag |
Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
|
US5110927A
(en)
*
|
1987-12-31 |
1992-05-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prazosin analog with increased selectivity and duration of action
|
DE3803225A1
(de)
*
|
1988-02-04 |
1989-08-17 |
Hoechst Ag |
Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
|
US5136044A
(en)
*
|
1988-04-04 |
1992-08-04 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
N2 -carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinolpril using the compound
|
IL90189A0
(en)
*
|
1988-06-01 |
1989-12-15 |
Squibb & Sons Inc |
Pharmaceutical compositions containing a benzazepine-type calcium channel blocker
|
GB8827308D0
(en)
*
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
GB8827305D0
(en)
*
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
SE506179C2
(sv)
*
|
1989-01-23 |
1997-11-17 |
Ciba Geigy Ag |
Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum
|
ZA902661B
(en)
*
|
1989-04-10 |
1991-01-30 |
Schering Corp |
Mercapto-acyl amino acids
|
DE3915236A1
(de)
*
|
1989-05-10 |
1990-11-15 |
Merck Patent Gmbh |
Pharmazeutische zubereitung
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
US5110799A
(en)
*
|
1989-07-28 |
1992-05-05 |
Merck & Co., Inc. |
Antiherpetic agents
|
DE3926606A1
(de)
*
|
1989-08-11 |
1991-02-14 |
Hoechst Ag |
Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
|
GB8919251D0
(en)
*
|
1989-08-24 |
1989-10-04 |
British Bio Technology |
Compounds
|
US5212165A
(en)
*
|
1989-10-23 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
|
US5389610A
(en)
*
|
1989-11-21 |
1995-02-14 |
Schering Corporation |
Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
|
AU7168091A
(en)
*
|
1989-12-22 |
1991-07-24 |
Schering Corporation |
Mercaptocycloacyl aminoacid endopeptidase inhibitors
|
US5075302A
(en)
*
|
1990-03-09 |
1991-12-24 |
Schering Corporation |
Mercaptoacyl aminolactam endopeptidase inhibitors
|
DE69124598T2
(de)
|
1990-05-11 |
1997-05-28 |
Pfizer |
Synergistische therapeutische zusammensetzungen und verfahren
|
US5821232A
(en)
*
|
1990-05-11 |
1998-10-13 |
Pfizer Inc. |
Synergistic therapeutic compositions and methods
|
US5166143A
(en)
*
|
1990-05-31 |
1992-11-24 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
|
US6300362B1
(en)
|
1990-07-25 |
2001-10-09 |
Novartis Ag (Formerly Sandoz Ltd.) |
Stabilized pharmaceutical compositions comprising acid donors
|
US5173506A
(en)
*
|
1990-08-16 |
1992-12-22 |
Schering Corporation |
N-(mercaptoalkyl)ureas and carbamates
|
TW197945B
(da)
*
|
1990-11-27 |
1993-01-11 |
Hoechst Ag |
|
EP0490379A3
(de)
*
|
1990-12-13 |
1992-06-24 |
BERLIN-CHEMIE Aktiengesellschaft |
Diaminosäurederivate und pharmazeutische Zusammensetzungen
|
US5124152A
(en)
*
|
1991-01-07 |
1992-06-23 |
Fisons Corporation |
Parenteral formulation of metolazone
|
GB9102635D0
(en)
*
|
1991-02-07 |
1991-03-27 |
British Bio Technology |
Compounds
|
US5530161A
(en)
*
|
1991-07-08 |
1996-06-25 |
British Bio-Technology Limited |
Hydroxamic acid based collagenase inhibitors
|
US5972990A
(en)
*
|
1992-04-10 |
1999-10-26 |
Brigham And Women's Hospital, Inc. |
Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
|
US5977160A
(en)
*
|
1992-04-10 |
1999-11-02 |
Brigham And Women's Hospital, Inc. |
Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
|
US5552397A
(en)
*
|
1992-05-18 |
1996-09-03 |
E. R. Squibb & Sons, Inc. |
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
|
US5504080A
(en)
*
|
1992-10-28 |
1996-04-02 |
Bristol-Myers Squibb Co. |
Benzo-fused lactams
|
US5589499A
(en)
*
|
1992-11-25 |
1996-12-31 |
Weth; Gosbert |
Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders
|
US5455353A
(en)
*
|
1993-03-24 |
1995-10-03 |
Hoffmann-La Roche Inc. |
4-(benzyl-2-oxo-oxazolidin-5 ylmethyl)N tertbutyl-decahydroisoquinoline-3-carboxamides
|
US5654294A
(en)
*
|
1993-05-13 |
1997-08-05 |
Bristol-Myers Squibb |
Spiro lactam dual action inhibitors
|
US5508272A
(en)
*
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
PT634175E
(pt)
*
|
1993-07-15 |
2001-06-29 |
Hoffmann La Roche |
Combinacao farmaceutica que contem um inibidor do sistema renina-angiotensina e o antagonista de endotelina
|
US5362727A
(en)
*
|
1993-07-26 |
1994-11-08 |
Bristol-Myers Squibb |
Substituted azepino[2,1-a]isoquinoline compounds
|
US5525723A
(en)
*
|
1993-11-18 |
1996-06-11 |
Bristol-Myers Squibb Co. |
Compounds containing a fused multiple ring lactam
|
JP3883205B2
(ja)
*
|
1994-03-29 |
2007-02-21 |
メルク エンド カンパニー インコーポレーテッド |
アンギオテンシン▲ii▼レセプタ遮断イミダゾールによるアテローム性動脈硬化症の治療
|
AU2394795A
(en)
*
|
1994-04-28 |
1995-11-29 |
Du Pont Merck Pharmaceutical Company, The |
Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
|
US5616775A
(en)
*
|
1994-05-05 |
1997-04-01 |
Bristol-Myers Squibb Co. |
Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
|
WO1996002564A1
(en)
*
|
1994-07-13 |
1996-02-01 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
|
US5562921A
(en)
*
|
1994-07-15 |
1996-10-08 |
Sherman; Bernard C. |
Stable solid pharmaceutical compositions containing enalapril maleate
|
US5601801A
(en)
*
|
1994-08-02 |
1997-02-11 |
Merck Frosst Canada, Inc. |
Radiolabelled angiotensin converting enzyme inhibitors
|
CN1065860C
(zh)
*
|
1994-08-27 |
2001-05-16 |
王隶书 |
提取盐酸甜菜碱工艺
|
DE4431530C2
(de)
*
|
1994-09-03 |
2002-01-31 |
Degussa |
Verfahren zur Herstellung von 2-[3(S)-Amino-2(R)-hydroxy-4-phenylbutyl]-N-tert.butyl-decahydro-(4aS,8aS)-isochinolin-3(S)-carboxamid
|
US5587375A
(en)
*
|
1995-02-17 |
1996-12-24 |
Bristol-Myers Squibb Company |
Azepinone compounds useful in the inhibition of ACE and NEP
|
EA000736B1
(ru)
|
1995-04-11 |
2000-02-28 |
Мерк Энд Ко., Инк. |
Способ получения дипептидов
|
US5877313A
(en)
*
|
1995-05-17 |
1999-03-02 |
Bristol-Myers Squibb |
Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
|
US7056935B2
(en)
|
1995-06-07 |
2006-06-06 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
US5635504A
(en)
*
|
1995-06-07 |
1997-06-03 |
Bristol-Myers Squibb Co. |
Diazepine containing dual action inhibitors
|
US20020042377A1
(en)
*
|
1995-06-07 |
2002-04-11 |
Steiner Joseph P. |
Rotamase enzyme activity inhibitors
|
US5650408A
(en)
*
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
US5859031A
(en)
*
|
1995-06-07 |
1999-01-12 |
Gpi Nil Holdings, Inc. |
Small molecule inhibitors of rotamase enzyme activity
|
CN1053437C
(zh)
*
|
1995-07-19 |
2000-06-14 |
五洲药厂 |
赖诺普利合成方法
|
US5573780A
(en)
*
|
1995-08-04 |
1996-11-12 |
Apotex Usa Inc. |
Stable solid formulation of enalapril salt and process for preparation thereof
|
US5550127A
(en)
*
|
1995-09-07 |
1996-08-27 |
Pantano; James A. |
Method of treatment for eiph in racing stock
|
CA2231043A1
(en)
*
|
1995-09-15 |
1997-03-20 |
Xue-Zhi Qin |
Method for analyzing isomers of enalapril and enalaprilat
|
US5670655A
(en)
*
|
1995-09-15 |
1997-09-23 |
Merck & Co. Inc. |
Method for analyzing isomers of enalapril and enalaprilat
|
US5801197A
(en)
*
|
1995-10-31 |
1998-09-01 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
WO1997049392A1
(en)
*
|
1996-06-24 |
1997-12-31 |
Merck & Co., Inc. |
A composition of enalapril and losartan
|
CA2182258C
(en)
*
|
1996-07-29 |
2001-04-17 |
K.S. Keshava Murthy |
Sodium enalapril complex and the use thereof to make sodium enalapril
|
US6218424B1
(en)
|
1996-09-25 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Heterocyclic ketone and thioester compounds and uses
|
US5801187A
(en)
|
1996-09-25 |
1998-09-01 |
Gpi-Nil Holdings, Inc. |
Heterocyclic esters and amides
|
US5786378A
(en)
*
|
1996-09-25 |
1998-07-28 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters
|
US5945441A
(en)
*
|
1997-06-04 |
1999-08-31 |
Gpi Nil Holdings, Inc. |
Pyrrolidine carboxylate hair revitalizing agents
|
US6187784B1
(en)
|
1998-06-03 |
2001-02-13 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivative hair growth compositions and uses
|
US6274602B1
(en)
|
1998-06-03 |
2001-08-14 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioester and ketone hair growth compositions and uses
|
US20010049381A1
(en)
|
1997-06-04 |
2001-12-06 |
Gpl Nil Holdings, Inc., |
Pyrrolidine derivative hair growth compositions and uses
|
US6271244B1
(en)
|
1998-06-03 |
2001-08-07 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
|
US6187796B1
(en)
|
1998-06-03 |
2001-02-13 |
Gpi Nil Holdings, Inc. |
Sulfone hair growth compositions and uses
|
US7378506B2
(en)
*
|
1997-07-21 |
2008-05-27 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
US6639050B1
(en)
*
|
1997-07-21 |
2003-10-28 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
US6548642B1
(en)
*
|
1997-07-21 |
2003-04-15 |
Ohio University |
Synthetic genes for plant gums
|
US6570062B1
(en)
*
|
1997-07-21 |
2003-05-27 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
IN184759B
(da)
|
1997-07-22 |
2000-09-23 |
Kaneka Corp |
|
IT1299341B1
(it)
*
|
1998-02-09 |
2000-03-16 |
Pfc Italiana Srl |
Processo per la produzione di alcossicarbonildipeptidi intermedi nella sintesi del lisinopril.
|
US6296871B1
(en)
|
1998-04-12 |
2001-10-02 |
Ranbaxy Laboratories Limited |
Stable solid pharmaceutical compositions containing enalapril maleate
|
US6172087B1
(en)
|
1998-06-03 |
2001-01-09 |
Gpi Nil Holding, Inc. |
N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
|
US6429215B1
(en)
|
1998-06-03 |
2002-08-06 |
Gpi Nil Holdings, Inc. |
N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
JP2002516843A
(ja)
*
|
1998-06-03 |
2002-06-11 |
ジー・ピー・アイ ニイル ホールディングス インコーポレィティッド |
ヘテロサイクリックエステルおよびアミド発毛組成物およびその使用
|
HUP0102935A3
(en)
|
1998-06-03 |
2002-01-28 |
Gpi Nil Holdings Inc Wilmingto |
N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres and pharmaceutical compositions containing them
|
IL139590A0
(en)
*
|
1998-06-05 |
2002-02-10 |
Warner Lambert Co |
Stabilization of compositions containing ace inhibitors using magnesium oxide
|
PL339360A1
(en)
|
1998-07-21 |
2000-12-18 |
Kaneka Corp |
Method of crystallising n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline maleate
|
US6399648B1
(en)
|
1998-08-14 |
2002-06-04 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
|
US7338976B1
(en)
|
1998-08-14 |
2008-03-04 |
Gpi Nil Holdings, Inc. |
Heterocyclic esters or amides for vision and memory disorders
|
US6333340B1
(en)
|
1998-08-14 |
2001-12-25 |
Gpi Nil Holdings, Inc. |
Small molecule sulfonamides for vision and memory disorders
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
US6395758B1
(en)
|
1998-08-14 |
2002-05-28 |
Gpi Nil Holdings, Inc. |
Small molecule carbamates or ureas for vision and memory disorders
|
US6335348B1
(en)
|
1998-08-14 |
2002-01-01 |
Gpi Nil Holdings, Inc. |
Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
|
US6506788B1
(en)
|
1998-08-14 |
2003-01-14 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
|
US6218423B1
(en)
|
1998-08-14 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Pyrrolidine derivatives for vision and memory disorders
|
US6339101B1
(en)
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
US6384056B1
(en)
|
1998-08-14 |
2002-05-07 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters or ketones for vision and memory disorders
|
US6337340B1
(en)
|
1998-08-14 |
2002-01-08 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
|
US6191144B1
(en)
|
1998-08-17 |
2001-02-20 |
Warner-Lambert Company |
Method of using angiotensin converting enzyme inhibitor to stimulate angiogenesis
|
US6462072B1
(en)
|
1998-09-21 |
2002-10-08 |
Gpi Nil Holdings, Inc. |
Cyclic ester or amide derivatives
|
EP1115389B1
(en)
|
1998-09-25 |
2014-03-12 |
PhilERA New Zealand Limited |
Fructosamine oxidase: antagonists and inhibitors
|
AU772616B2
(en)
*
|
1998-09-25 |
2004-05-06 |
Protemix Corporation Limited |
Fructosamine oxidase assay: methods and materials
|
NZ333206A
(en)
|
1998-12-08 |
2000-07-28 |
Bernard Charles Sherman |
Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
|
US6048874A
(en)
*
|
1999-01-26 |
2000-04-11 |
Medeva Pharmaceuticals Manufacturing, Inc. |
Parenteral metolazone formulations
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
CA2382547A1
(en)
*
|
1999-09-21 |
2001-03-29 |
Stephen R. Hanson |
Methods and compositions for treating platelet-related disosders
|
US20030113330A1
(en)
*
|
1999-11-08 |
2003-06-19 |
Uhal Bruce D. |
Methods for treating pulmonary fibrosis
|
US6569456B2
(en)
|
2000-01-13 |
2003-05-27 |
Osmotica Corp. |
Osmotic device containing diltiazem and an ACE inhibitor or diuretic
|
BR0108077A
(pt)
*
|
2000-02-04 |
2002-10-22 |
Children S Hospital Res Founda |
Processo para reduzir placas ateroscleróticas em um mamìfero, método para tratamento da aterosclerose em um mamìfero, composição, métodos para prover proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo ou mistura deles, para células de um mamìfero tendo deficiência na proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo , para prover lipase de ácido lisossomal biologicamente ativa para células de um mamìfero tendo deficiência de lipase de ácido lisossomal biologicamente ativa, para prover lipase de ácido lisossoal biologicamente ativa para células de um mamìfero com aterosclerose, para tratamento da doença de wolman em um mamìfero, para tratamento de doença de armazenagem de colesteril éster em um mamìfero, e, para tratamento da aterosclerose em um mamìfero
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
EP1386165B1
(en)
|
2000-12-14 |
2011-11-02 |
The Brigham And Women's Hospital, Inc. |
Inflammatory markers for detection and prevention of diabetes mellitus
|
US6458769B1
(en)
|
2001-06-25 |
2002-10-01 |
Astrazeneca Ab |
Amorphous compound
|
US6462174B1
(en)
|
2001-06-25 |
2002-10-08 |
Astrazeneca Ab |
Amorphous compound
|
US6627760B1
(en)
|
2001-06-25 |
2003-09-30 |
Astrazeneca Ab |
Amorphous compound
|
US6984645B2
(en)
*
|
2001-11-16 |
2006-01-10 |
Bristol-Myers Squibb Company |
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
|
SI21101A
(sl)
*
|
2001-11-26 |
2003-06-30 |
LEK farmacevtska dru�ba d.d. |
Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo
|
US20030215526A1
(en)
*
|
2002-03-08 |
2003-11-20 |
Scott Stofik |
Stable formulations of angiotensin converting enzyme (ACE) inhibitors
|
AU2003225442B2
(en)
|
2002-03-08 |
2010-02-04 |
Philera New Zealand Limited |
Preventing and/or treating cardiovascular disease and/or associated heart failure
|
ATE534747T1
(de)
|
2002-05-09 |
2011-12-15 |
Brigham & Womens Hospital |
1l1rl-1 als marker für kardiovaskuläre erkrankungen
|
DE60213880T2
(de)
*
|
2002-06-19 |
2007-01-18 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. |
Verfahren zur herstellung von lisinopril
|
RS20050106A
(en)
|
2002-08-19 |
2007-11-15 |
Pfizer Products Inc., |
Combination therapy for hyperproliferative diseases
|
CA2875522A1
(en)
|
2002-08-20 |
2004-03-04 |
Philera New Zealand Limited |
Dosage forms and related therapies
|
CN1283658C
(zh)
*
|
2002-09-11 |
2006-11-08 |
东亚荣养株式会社 |
脯氨酸酯类及含有它的经皮给予制剂
|
US20040110241A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
EP1585500B8
(en)
|
2002-12-20 |
2017-07-26 |
Auritec Pharmaceuticals |
Coated particles for sustained-release pharmaceutical administration
|
CL2004000366A1
(es)
*
|
2003-02-26 |
2005-01-07 |
Pharmacia Corp Sa Organizada B |
USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
|
CL2004000544A1
(es)
*
|
2003-03-18 |
2005-01-28 |
Pharmacia Corp Sa Organizada B |
Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
|
US20060252120A1
(en)
*
|
2003-05-09 |
2006-11-09 |
Kieliszewski Marcia J |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
SG141430A1
(en)
|
2003-05-30 |
2008-04-28 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
US7459474B2
(en)
*
|
2003-06-11 |
2008-12-02 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
US20040265238A1
(en)
*
|
2003-06-27 |
2004-12-30 |
Imtiaz Chaudry |
Inhalable formulations for treating pulmonary hypertension and methods of using same
|
US20060089374A1
(en)
*
|
2003-07-17 |
2006-04-27 |
Glenn Cornett |
Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
|
GB2419529B
(en)
*
|
2003-07-17 |
2008-01-09 |
Cotherix Inc |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
US7491743B2
(en)
|
2003-08-29 |
2009-02-17 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis
|
US7371759B2
(en)
*
|
2003-09-25 |
2008-05-13 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US20050153885A1
(en)
*
|
2003-10-08 |
2005-07-14 |
Yun Anthony J. |
Treatment of conditions through modulation of the autonomic nervous system
|
US7420059B2
(en)
*
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
CA2549236C
(en)
|
2003-12-05 |
2017-06-13 |
The Cleveland Clinic Foundation |
Risk markers for cardiovascular disease
|
WO2005058294A1
(en)
*
|
2003-12-19 |
2005-06-30 |
Protemix Corporation Limited |
Copper antagonist compounds
|
MXPA06008126A
(es)
*
|
2004-01-14 |
2008-02-14 |
Univ Ohio |
Metodos para la produccion de peptidos/proteinas en plantas y peptidos/proteinas producidos de este modo.
|
EP1751177A4
(en)
*
|
2004-04-19 |
2008-07-16 |
Univ Ohio |
NETWORKABLE GLYCOPROTEINS AND METHOD FOR THEIR PRODUCTION
|
US7803838B2
(en)
*
|
2004-06-04 |
2010-09-28 |
Forest Laboratories Holdings Limited |
Compositions comprising nebivolol
|
CA3050047A1
(en)
|
2004-07-19 |
2006-03-16 |
Philera New Zealand Limited |
Synthesis of triethylenetetramines
|
EP1809759B1
(en)
|
2004-10-06 |
2013-09-11 |
The Brigham And Women's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
JP2008528626A
(ja)
*
|
2005-01-31 |
2008-07-31 |
マイラン ラボラトリーズ インク. |
ヒドロキシル化されたネビボロールを含む薬学的組成物
|
ZA200710880B
(en)
*
|
2005-05-27 |
2009-06-24 |
Univ Cape Town |
Angiotensin I-converting enzyme (ace) inhibitors
|
SG162734A1
(en)
|
2005-05-31 |
2010-07-29 |
Mylan Lab Inc |
Compositions comprising nebivolol
|
WO2007008708A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Ohio University |
Methods of predicting hyp-glycosylation sites for proteins expressed and secreted in plant cells, and related methods and products
|
WO2007030375A2
(en)
*
|
2005-09-08 |
2007-03-15 |
Children's Hospital Medical Center |
Lysosomal acid lipase therapy for nafld and related diseases
|
US8119358B2
(en)
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
BRPI0618379A2
(pt)
|
2005-11-08 |
2011-08-30 |
Ranbaxy Lab Ltd |
processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
CA2634473A1
(en)
*
|
2006-02-17 |
2007-08-30 |
Nitromed, Inc. |
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
JP5412273B2
(ja)
*
|
2006-03-21 |
2014-02-12 |
アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー |
ペプチド−ぺプチダーゼ阻害剤及びその使用
|
US20070238770A1
(en)
*
|
2006-04-05 |
2007-10-11 |
Bristol-Myers Squibb Company |
Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
|
EP2302395B1
(en)
|
2006-06-07 |
2015-04-15 |
Health Diagnostic Laboratory, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
EP2099767A1
(en)
|
2006-11-01 |
2009-09-16 |
Brystol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
|
WO2008057862A2
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
|
ATE547394T1
(de)
|
2006-12-01 |
2012-03-15 |
Bristol Myers Squibb Co |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
|
EP2541254B1
(en)
|
2007-04-18 |
2014-11-12 |
Health Diagnostic Laboratory, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8598314B2
(en)
*
|
2007-09-27 |
2013-12-03 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase-inhibitor conjugates and methods of making and using same
|
US20090118258A1
(en)
*
|
2007-11-07 |
2009-05-07 |
Bruce Damiano |
Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists
|
US7828840B2
(en)
*
|
2007-11-15 |
2010-11-09 |
Med Institute, Inc. |
Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
|
AU2009256157B2
(en)
|
2008-06-04 |
2014-12-18 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
SI23149A
(sl)
|
2009-09-21 |
2011-03-31 |
Silverstone Pharma |
Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
|
US8119817B2
(en)
*
|
2009-09-29 |
2012-02-21 |
Degussa-Huels Ag |
Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
|
EP2531163A1
(en)
|
2010-02-01 |
2012-12-12 |
The Hospital For Sick Children |
Remote ischemic conditioning for treatment and preventon of restenosis
|
EP2552331B1
(en)
|
2010-03-31 |
2020-01-08 |
The Hospital For Sick Children |
Use of remote ischemic conditioning to improve outcome after myocardial infarction
|
AU2011237461B2
(en)
|
2010-04-08 |
2015-11-26 |
The Hospital For Sick Children |
Use of remote ischemic conditioning for traumatic injury
|
EP2585051B2
(en)
|
2010-06-23 |
2020-04-08 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
SI2651896T1
(sl)
|
2010-12-15 |
2015-11-30 |
Theravance Biopharma R&D Ip, Llc |
Inhibitorji neprilizina
|
NZ611528A
(en)
|
2010-12-15 |
2015-06-26 |
Theravance Biopharma R & D Ip Llc |
Neprilysin inhibitors
|
EP2654729B1
(en)
|
2010-12-24 |
2016-05-04 |
KRKA, d.d., Novo mesto |
Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
|
CN103380119B
(zh)
|
2011-02-17 |
2016-02-17 |
施万生物制药研发Ip有限责任公司 |
作为脑啡肽酶抑制剂的经取代的氨基丁酸衍生物
|
EP2675792B1
(en)
|
2011-02-17 |
2016-01-06 |
Theravance Biopharma R&D IP, LLC |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
EP2714660B1
(en)
|
2011-05-31 |
2018-09-26 |
Theravance Biopharma R&D IP, LLC |
Neprilysin inhibitors
|
EP2714648B1
(en)
|
2011-05-31 |
2017-08-16 |
Theravance Biopharma R&D IP, LLC |
Neprilysin inhibitors
|
JP5959074B2
(ja)
|
2011-05-31 |
2016-08-02 |
セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー |
ネプリライシン阻害剤
|
EP3173093B1
(en)
|
2011-07-18 |
2018-12-05 |
Critical Care Diagnostics, Inc. |
Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
|
WO2013030725A1
(en)
|
2011-08-26 |
2013-03-07 |
Wockhardt Limited |
Methods for treating cardiovascular disorders
|
TWI560172B
(en)
|
2011-11-02 |
2016-12-01 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
WO2013170186A1
(en)
|
2012-05-11 |
2013-11-14 |
Reset Therapeutics, Inc. |
Carbazole-containing sulfonamides as cryptochrome modulators
|
CA2871292A1
(en)
|
2012-05-31 |
2013-12-05 |
Theravance Biopharma R&D Ip, Llc |
Nitric oxide donor neprilysin inhibitors
|
ES2710932T3
(es)
|
2012-06-08 |
2019-04-29 |
Theravance Biopharma R&D Ip Llc |
Inhibidores de neprilisina
|
RU2663618C2
(ru)
|
2012-06-08 |
2018-08-07 |
ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи |
Ингибиторы неприлизина
|
EP2879666B1
(en)
|
2012-08-01 |
2020-04-08 |
Tavakoli, Zahra |
Free flowing, frozen compositions comprising a therapeutic agent
|
DK2882716T3
(da)
|
2012-08-08 |
2017-03-06 |
Theravance Biopharma R&D Ip Llc |
Neprilysin hæmmere
|
US8568747B1
(en)
|
2012-10-05 |
2013-10-29 |
Silvergate Pharmaceuticals, Inc. |
Enalapril compositions
|
WO2014138053A1
(en)
|
2013-03-05 |
2014-09-12 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
WO2014145022A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Hybrid necroptosis inhibitors
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
EP2976062B1
(en)
|
2013-03-21 |
2021-11-03 |
Eupraxia Pharmaceuticals USA LLC |
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
|
AU2014255381A1
(en)
|
2013-04-17 |
2015-10-08 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
WO2014197720A2
(en)
|
2013-06-05 |
2014-12-11 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
WO2015027021A1
(en)
|
2013-08-22 |
2015-02-26 |
Bristol-Myers Squibb Company |
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
|
WO2015116760A1
(en)
|
2014-01-30 |
2015-08-06 |
Theravance Biopharma R&D Ip, Llc |
5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
|
CN105992763A
(zh)
|
2014-01-30 |
2016-10-05 |
施万生物制药研发Ip有限责任公司 |
脑啡肽酶抑制剂
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
PT3193826T
(pt)
|
2014-07-31 |
2019-01-23 |
Pharmathen Sa |
Composição de película orodispersível compreendendo enalapril para o tratamento de hipertensão numa população pediátrica
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
EP3256446B1
(en)
|
2015-02-11 |
2022-05-18 |
Theravance Biopharma R&D IP, LLC |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
|
BR112017017783A2
(pt)
|
2015-02-19 |
2018-07-17 |
Theravance Biopharma R&D Ip, Llc |
Ácido (2r,4r)-5-(5'-cloro-2'-fluorbifenil-4-il)-2-hidróxi- 4-[(5-metiloxazol-2-carbonil)amino]pentanóico.
|
US11351124B2
(en)
|
2015-10-27 |
2022-06-07 |
Eupraxia Pharmaceuticals Inc. |
Sustained release of formulations of local anesthetics
|
US9463183B1
(en)
|
2015-10-30 |
2016-10-11 |
Silvergate Pharmaceuticals, Inc. |
Lisinopril formulations
|
JP7306828B2
(ja)
|
2016-03-08 |
2023-07-11 |
セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー |
結晶性(2s,4r)-5-(5’-クロロ-2’-フルオロ-[1,1’-ビフェニル]-4-イル)-2-(エトキシメチル)-4-(3-ヒドロキシイソオキサゾール-5-カルボキサミド)-2-メチルペンタン酸およびその使用
|
US9669008B1
(en)
|
2016-03-18 |
2017-06-06 |
Silvergate Pharmaceuticals, Inc. |
Enalapril formulations
|
WO2018097999A1
(en)
*
|
2016-11-23 |
2018-05-31 |
The Regents Of The University Of California |
Compositions and methods for modulating protease activity
|
WO2019084455A1
(en)
*
|
2017-10-26 |
2019-05-02 |
Southern Research Institute |
DIPEPTIDE ANALOGS AS TGF-BETA INHIBITORS
|
CN109734775A
(zh)
*
|
2018-12-31 |
2019-05-10 |
辰欣药业股份有限公司 |
一种马来酸依那普利的精制方法
|
JOP20210193A1
(ar)
|
2019-01-18 |
2023-01-30 |
Astrazeneca Ab |
مثبطات pcsk9 وطرق استخدامها
|
GB2595203A
(en)
|
2020-03-03 |
2021-11-24 |
Alkaloid Ad Skopje |
Formulation
|